Clinical Trial Update: Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Bictegravir/Emtricitabine/Tenofovir Alafenamide to a Dolutegravir-based regimen in treatment-naive adults co-infected with HIV-1 and Hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Bictegravir/Emtricitabine/Tenofovir Alafenamide (Bictegravir/emtricitabine/tenofovir alafenamide)
• Dolutegravir/Emtricitabine/Tenofovir Disoproxil Fumarate (Dolutegravir/emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1/HBV Co-Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-03-15